Invesco Bloomberg Pricing Power ETF (DEF) Price, Holdings, & News

ETF Overview

Guggenheim Defensive Equity ETF (the Fund) seeks investment results, which correspond to the performance, before the Fund's fees and expenses, of an equity index called the Sabrient Defensive Equity Index (the Index). The Index is consisted of approximately 100 securities selected, based on investment and other criteria developed by Sabrient Systems LLC (Sabrient), from a universe of the United States-traded securities, including master limited partnerships (MLPs) and American depositary receipts (ADRs). The Fund will invest at least 90% of its total assets in common stock, ADRs and MLPs, which comprise the Index and depositary receipts representing common stocks included in the Index (or underlying securities representing ADRs included in the Index). Guggenheim Funds Investment Advisors, LLC is investment adviser of the Fund.

Key Stats

• Today's Range: $87.12 to $87.45
• 50-Day Range: $82.71 to $88.06
• 52-Week Range: $59.14 to $70.92
• Volume: 1,142 shs
• Average Volume: 16,975 shs
• Market Capitalization: $282.27 million
• Assets Under Management: $217.19 million
• Dividend Yield: 1.12%
• Net Expense Ratio: 0.54%
• Aggregate Rating: Moderate Buy

DEF ETF - Frequently Asked Questions

How have DEF shares performed this year?

Invesco Bloomberg Pricing Power ETF's stock was trading at $82.2259 at the beginning of 2025. Since then, DEF shares have increased by 6.0% and is now trading at $87.1208.

How do I buy shares of Invesco Bloomberg Pricing Power ETF?

Shares of DEF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Invesco Bloomberg Pricing Power ETF own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Invesco Bloomberg Pricing Power ETF investors own include Bristol Myers Squibb (BMY), AbbVie (ABBV), Abbott Laboratories (ABT), Allergan (AGN), Cisco Systems (CSCO), CVS Health (CVS) and DexCom (DXCM).

Fund Details

• Issuer: Invesco
• Fund Name: Invesco Defensive Equity ETF
• Tax Classification: Regulated Investment Company
• Stock Exchange: NYSEARCA
• Current Symbol: NYSEARCA:DEF
• Inception Date: 12/15/2006
• Fund Manager: Peter Hubbard, Michael Jeanette, Pratik Doshi, Tony Seisser
• Web: www.guggenheimfunds.com
• Phone: +1-630-5053700

Fund Focus

• Asset Class: Equity
• Benchmark: Invesco Defensive Equity Index
• Category: Strategy
• Focus: Alpha-Seeking
• Development Level: Developed Markets
• Region: North America
• Number of Holdings: 104

Fund Statistics

• Assets Under Management: $217.19 million
• Average Daily Volume: $30.14 thousand
• Discount/Premium: 0.05%

Administrator, Advisor and Custodian

• Administrator: The Bank of New York Mellon Corporation
• Advisor: Invesco Capital Management LLC
• Custodian: The Bank of New York Mellon Corporation
• Distributor: Invesco Distributors, Inc.
• Transfer Agent: The Bank of New York Mellon Corporation
• Trustee: N/A
• Lead Market Maker: IMC

Options

• Optionable: N/A
• Short Interest: 100 shs

Miscellaneous

• Outstanding Shares: 3,240,000
• Beta: 0.85
• Creation Unit: 10,000
• Creation Fee: $500.00